News

Bluerock Value Exchange Closes $36.7 Million Investment Fund

Bluerock Value Exchange Closes $36.7 Million Investment Fund

Bluerock Value Exchange Achieves Full Subscription of $36.7 Million Fund

Bluerock Value Exchange (BVEX), a nationally recognized sponsor with two decades of experience in 1031 exchange and Delaware Statutory Trust (DST) investment programs, recently announced a significant milestone. The company has fully subscribed the BR Diversified Industrial Portfolio V, DST (DIP IV) at an impressive value of $36.7 million in equity sourced from individual investors. This achievement is underscored by Bluerock's impressive history, which includes managing over $2.8 billion in various 1031 exchange programs.

Josh Hoffman, the President of Bluerock Value Exchange, expressed his satisfaction, stating, "We are pleased with the successful completion of our fifth diversified industrial portfolio DST representing over $246 million in tax-deferred 1031 exchange investments. Our team believes that the industrial sector has significant potential for net operating income (NOI) growth, fueled by ongoing trends in manufacturing and distribution that are propelling demand forward. Through diversified portfolios, we strive to meet our investors' goals of capital preservation, stable income, and attractive risk-adjusted returns over a moderate investment horizon."

Insights into the DIP V Investment Strategy

The DIP V offering stands out due to its all-cash structure, featuring two key states' industrial sector portfolios encompassing approximately 255,000 square feet. This portfolio consists of essential manufacturing, warehouse, and highly sought-after outdoor storage and distribution properties, all fully leased to two credit-rated, publicly traded tenants. The strategic location and leasing agreements ensure reliability and consistent cash flow for investors.

This investment is designed to provide participants with stable monthly cash flow through long-term triple net leases, alongside the potential for capital appreciation. There is a strong expectation for future rent growth and NOI enhancement, given that current rental rates are roughly 20% lower than market averages. The DST program also offers investors flexible exit strategies, including options for a 721 exchange (UPREIT) or future 1031 exchanges with cash-out alternatives.

About Bluerock Value Exchange

With a solid track record spanning 20 years, Bluerock Value Exchange has established itself as a leading national sponsor of syndicated 1031-exchange offerings centered on Premier Exchange Properties™. The company's aim is to provide investors with stable cash flows alongside potential for value appreciation. To date, Bluerock has successfully structured 1031 exchanges valuing over $2.8 billion and encompassing a total of 14.9 million square feet of property.

Bluerock's Commitment to Innovation

As a noteworthy institutional alternative asset manager, Bluerock has amassed $19 billion in acquired and managed assets, with headquarters in Manhattan and regional offices across the United States. The firm has a combined expertise of over 100 years among its principals in real estate investment and capital markets. Their successful track record includes more than $120 billion in related experience, facilitating the launch of several prominent private and public sector platforms.

Recognizing the Industry's Future

Bluerock's approach underscores a keen understanding of market dynamics and investor needs. They consistently convey confidence in the industrial real estate sector's potential, driven by robust demand trends. Their comprehensive strategy points to an ongoing commitment to transparency and accountability in dealing with investors.

Looking Forward

As the company continues to pursue innovative investment opportunities, Bluerock Value Exchange remains dedicated to growing its portfolio and maximizing returns for its investors. The success of the BR Diversified Industrial Portfolio V illustrates not only investor confidence in Bluerock's strategy but also signifies the company's ability to adapt to shifting market conditions.

Frequently Asked Questions

What is the BR Diversified Industrial Portfolio V?

The BR Diversified Industrial Portfolio V is a DST investment program that has fully raised $36.7 million for industrial properties, focusing on stable cash flows and value creation.

How does the investment strategy work?

This strategy primarily involves long-term triple net leases which provide stable income, as well as the potential for capital appreciation driven by rental growth.

What are the key benefits for investors?

Investors can expect stable returns from cash flows, along with the opportunity for future rent increases and various exit strategies.

Why is the industrial sector appealing for investments?

The industrial sector is currently experiencing strong demand due to trends in manufacturing and distribution, which suggests robust growth potential.

How can I learn more about Bluerock Value Exchange?

Further information about their offerings and performance can be found through their official website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

AIP Realty Trust Announces Successful Non-Brokered Offering

Updated Category News Views 177

AIP Realty Trust's Financial Milestone Achieved AIP Realty Trust has made waves in the investment community by successfully finalizing the initial tranche of a significant non-brokered private placement. These efforts have brought in an impressive total of 7,260,000 Preferred Units—Series B Convertible, valued at US$0.50 each, resulting in gross proceeds of...

Continue Reading
Medtronic's BrainSense™ Receives CE Marking for Parkinson's Care

Updated Category News Views 499

Medtronic’s Innovative Approval for Parkinson's Treatment Medtronic plc (NYSE: MDT), a global leader in healthcare technologies, has achieved a significant milestone by receiving CE Mark approval for its BrainSense™ Adaptive deep brain stimulation (aDBS) system and the BrainSense™ Electrode Identifier (EI). This remarkable advancement introduces the world's first...

Continue Reading
Understanding the New Rating for abrdn Asia-Pacific Income Fund

Updated Category News Views 84

KBRA's Rating Insights on abrdn Asia-Pacific Income Fund Recently, KBRA has taken significant steps by assigning a new rating to the Series B Mandatory Redeemable Preferred Shares (MRPS) of abrdn Asia-Pacific Income Fund, Inc. (NYSE: FAX). This rating stands at 'AA-', illustrating the organization's confidence in the stability and security of these investment instruments....

Continue Reading
Protect Your Investment: Join the Applied Therapeutics Class Action

Updated Category News Views 156

Understanding the Class Action for Applied Therapeutics Investors As an investor in Applied Therapeutics, Inc. (APLT), you may have felt the financial impact of recent challenges the company has encountered. The firm is currently facing a class action lawsuit aimed at addressing securities fraud that adversely affected investors between specific dates. This situation is...

Continue Reading
Heritage Capital Group Facilitates Mittauer's Strategic Sale

Updated Category News Views 205

Heritage Capital Group Facilitates Mittauer's Strategic Sale Heritage Capital Group, Inc. ("Heritage"), a respected investment banking and financial advisory firm known for serving middle-market and emerging growth companies, has successfully guided its client, Mittauer & Associates, Inc. ("Mittauer"), through a significant transition in its business landscape. This...

Continue Reading